Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. (NRIX) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 325 transactions totaling $8.8M, demonstrating a bearish sentiment with -$8.8M in net insider flow. The most recent transaction on Feb 10, 2026 involved a transaction of 562,500 shares valued at $0.
NRIX Insider Activity Summary
Who Is Buying NRIX Stock?
No significant insider buying has been recorded for NRIX in the recent period.
Who Is Selling NRIX Stock?
No significant insider selling has been recorded for NRIX in the recent period.
Is Nurix Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NRIX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$8.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
NRIX Frequently Asked Questions
Understanding NRIX Insider Activity
Insider trading at Nurix Therapeutics, Inc. (NRIX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading NRIX stock, having executed 325 transactions in the past 90 days. The most active insider is Houte Hans Van (Executive), who has made 60 transactions totaling $3.9M.
Related Tools
Track Nurix Therapeutics, Inc. Insider Activity
Get notified when executives and directors at NRIX file new Form 4 transactions